Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04965181 · ClinicalTrials.gov registry record · NA
Mindfulness-based Smoking Cessation Enhanced With Mobile Technology
A NA study, sponsored by Georgia State University.
- Completed
- Registry status
- NA
- Development phase
- 504
- Enrollment target
NCT04965181: Completed NA study, sponsored by Georgia State University.
NCT04965181 is a NA study that has completed, run by Georgia State University. The registered enrollment target is 504 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04965181, a NA study, has completed, sponsored by Georgia State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 504 participants
- Enrollment target
Study Summary
The purpose of this study is to: Aim I: Test the efficacy of a mindfulness-based text messaging program for smoking cessation ("iQuit Mindfully"), both as a standalone intervention and in combination with in-person counseling; and Aim II: Investigate the mechanisms through which mindfulness training impacts smoking cessation.
Primary Outcome
Self-report of not smoking any combustible tobacco products in the past 7 days (not even a puff), confirmed by expired carbon monoxide \<6 ppm
Interventions
- DRUG Nicotine Replacement Therapy
- BEHAVIORAL Self-help materials
- BEHAVIORAL iQuit Mindfully
- BEHAVIORAL Mindfulness-Based Addiction Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 504 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2025-01-09 |
| Phase | NA |
What the finished NCT04965181 record still lists
NCT04965181 is an interventional study that assigns participants to a tested intervention. The registered 504 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 4 interventions - of which Nicotine Replacement Therapy is the first listed.
NCT04965181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04965181 about?
NCT04965181 is a clinical study titled "Mindfulness-based Smoking Cessation Enhanced With Mobile Technology". The purpose of this study is to: Aim I: Test the efficacy of a mindfulness-based text messaging program for smoking cessation ("iQuit Mindfully"), both as a standalone intervention and in combination with in-person counseling; and Aim II: Investigate the mechanisms through which mindfulness trainin...
What is the current status of trial NCT04965181?
This trial is currently completed. It is a NA study. The enrollment target is 504 participants. The study started on 2021-07-01. Estimated completion is 2025-01-09.
What interventions are being tested in trial NCT04965181?
The interventions under investigation include: Nicotine Replacement Therapy (DRUG), Self-help materials (BEHAVIORAL), iQuit Mindfully (BEHAVIORAL), Mindfulness-Based Addiction Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04965181?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04965181's enrollment target sits among peer trials
504 193rd of 2000 higher than 1,808 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05846282 · 504 participants · NA
Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience
- NCT06072131 · 504 participants · Phase 3
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
- NCT06736522 · 504 participants · NA
Future Leaders Program: Testing a Youth Leadership, Engagement, and Mindfulness Program
- NCT06822257 · 504 participants · NA
Drinking in Young Adult Duos (DYAD) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI